Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -91.52% is 31% below its 5-year average of -69.81%, near the low end of its 5-year range (-115.25%–51.23%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.90% below its 12-month average of -88.94%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -91.52%.
RETURN ON EQUITY (ROE)
-91.52%
RETURN ON EQUITY (ROE) AVG TTM
-88.94%
RETURN ON EQUITY (ROE) AVG 3Y
-77.04%
RETURN ON EQUITY (ROE) AVG 5Y
-69.81%
RETURN ON EQUITY (ROE) AVG 10Y
-50.16%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.90%
CURRENT VS 3Y AVG
-18.80%
CURRENT VS 5Y AVG
-31.10%
CURRENT VS 10Y AVG
-82.44%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-117.85%
vs the sector median at left
Silo Pharma, Inc.
Market Cap
$1.63M
Return on Equity (ROE)
-91.52%
TTM Avg
-88.94%
3Y Avg
-77.04%
5Y Avg
-69.81%
Market Cap
$1.48M
Return on Equity (ROE)
-169.64%
TTM Avg
97.92%
3Y Avg
65.28%
5Y Avg
65.28%
Market Cap
$1.47M
Return on Equity (ROE)
-80.57%
TTM Avg
-96.07%
3Y Avg
-115.92%
5Y Avg
51.19%
Market Cap
$1.46M
Return on Equity (ROE)
-450.54%
TTM Avg
292.29%
3Y Avg
55.45%
5Y Avg
24.80%
Market Cap
$1.83M
Return on Equity (ROE)
-30.92%
TTM Avg
247.31%
3Y Avg
-294.42%
5Y Avg
-190.41%
Market Cap
$1.44M
Return on Equity (ROE)
-124.97%
TTM Avg
-62.14%
3Y Avg
-63.41%
5Y Avg
-579.67%
Market Cap
$1.43M
Return on Equity (ROE)
-32.05%
TTM Avg
-197.10%
3Y Avg
-44.98%
5Y Avg
-69.38%
Market Cap
$1.84M
Return on Equity (ROE)
N/A
TTM Avg
-239.06%
3Y Avg
-695.85%
5Y Avg
-455.08%
Market Cap
$1.81M
Return on Equity (ROE)
-615.03%
TTM Avg
-210.38%
3Y Avg
-268.95%
5Y Avg
-212.66%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Silo Pharma, Inc. (SILO) | $1.63M | -91.52% | -88.94% | -77.04% | -69.81% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.48M | -169.64% | 97.92% | 65.28% | 65.28% |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | -80.57% | -96.07% | -115.92% | 51.19% |
| Curis, Inc. (CRIS)vs › | $1.46M | -450.54% | 292.29% | 55.45% | 24.80% |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.83M | -30.92% | 247.31% | -294.42% | -190.41% |
| NEXGEL, Inc. (NXGL)vs › | $1.44M | -124.97% | -62.14% | -63.41% | -579.67% |
| INVO Fertility, Inc. (IVF)vs › | $1.43M | -32.05% | -197.10% | -44.98% | -69.38% |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | N/A | -239.06% | -695.85% | -455.08% |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | -615.03% | -210.38% | -268.95% | -212.66% |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.88M | N/A | 71.06% | 42.93% | 36.81% |
ROE
-91.5%
ROA
-75.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -91.52% |
| 2026-03-31 | -85.24% |
| 2025-12-31 | -67.05% |
| 2025-09-30 | -101.36% |
| 2025-06-30 | -99.55% |
| 2025-03-31 | -115.25% |
| 2024-12-31 | -87.26% |
| 2024-09-30 | -55.78% |
| 2024-06-30 | -58.99% |
| 2024-03-31 | -67.95% |
| 2023-12-31 | -59.91% |
| 2023-09-30 | -56.59% |
| 2023-06-30 | -55.03% |
| 2023-03-31 | -44.59% |
| 2022-12-31 | -37.80% |
| 2022-09-30 | -28.13% |
| 2022-06-30 | 51.23% |
| 2022-03-31 | 49.75% |
| 2021-12-31 | 43.08% |
| 2021-09-30 | 41.40% |
| 2021-06-30 | -74.79% |
| 2021-03-31 | -88.21% |
| 2020-12-31 | -237.18% |
| 2020-09-30 | -127.01% |
| 2020-06-30 | -83.62% |
| 2019-03-31 | -379.45% |
| 2018-12-31 | -237.94% |
| 2018-09-30 | -28.78% |
| 2018-06-30 | -67.50% |
| 2018-03-31 | -30.37% |
| 2017-12-31 | 29.64% |
| 2017-09-30 | 0.67% |
| 2017-06-30 | 6.22% |
| 2017-03-31 | -16.59% |
| 2016-12-31 | -131.48% |
| 2016-09-30 | -97.34% |
| 2016-06-30 | -69.85% |
| 2016-03-31 | -29.22% |
| 2015-12-31 | -20.90% |
| 2015-09-30 | -22.97% |
| 2015-06-30 | -13.69% |
| 2015-03-31 | -32.17% |
| 2014-12-31 | -15.88% |
| 2014-09-30 | -10.17% |
| 2014-06-30 | 4.01% |
| 2014-03-31 | 19.49% |
| 2013-12-31 | 1.84% |
| 2013-09-30 | -11.64% |
| 2013-06-30 | -19.82% |
